Respiratory/Pulmonary Market Research Reports & Industry Analysis
Respiratory/Pulmonary Industry Research & Market Reports
-
RESPIRATORY INFECTION DIAGNOSTIC MARKETS BY TECHNOLOGY, PLEX, PLACE AND BY REGION WITH COVID-19 IMPACT & FORECASTING/ANALYSIS, AND EXECUTIVE AND CONSULTANT GUIDES 2021-2025
... testing of respiratory infections. Now the competition for market share begins in earnest. Large new markets are opening up. In health facilities, clinics, physicians’ offices and elsewhere. And lets not forget the screening market, not ... Read More
-
Bronchitis– Pipeline Insight, 2020
... also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Bronchitis Understanding Bronchitis: Overview Bronchitis ... Read More
-
Global and Japan Respiratory Drug Market Insights, Forecast to 2026
... global Respiratory Drug market size was US$ 38985 million and it is expected to reach US$ 57097 million by the end of 2026, with a CAGR of 5.82% during 2021-2026. In Japan the Respiratory Drug ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2020
... the Chronic Obstructive Pulmonary Disease (Respiratory) pipeline landscape. Chronic obstructive pulmonary disease (COPD) is a group of lung diseases. It is characterized by inability to completely breathe out air from the lungs leading to shortness ... Read More
-
Cystic Fibrosis - Pipeline Review, H2 2020
... landscape. Cystic fibrosis (CF) is an inherited disease that causes mucus to build up and clog some of the body’s organs, particularly the lungs and pancreas. Cystic fibrosis affects the cells that produce mucus, sweat ... Read More
-
Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2020
... Fibrosis (Respiratory) pipeline landscape. Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease characterized by inflammation and scarring of lung tissue and loss of lung function. Symptoms of IPF include dry cough, shortness of ... Read More
-
SYNDROMIC MULTIPLEX DIAGNOSTIC MARKETS with COVID-19 IMPACTS. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Country. With Market Analysis, Executive Guides and Customization. 2021 to 2025
... affect Syndromic and Infectious Disease Diagnostics? The COVID pandemic is ushering in a new world of infectious disease diagnostics. Infectious disease Dx is changing and will change more in the future. Can a rapidly growing ... Read More
-
Pulmonary Fibrosis Disease - Global Clinical Trials Review, H2 2020
... 2020 provides an overview of Pulmonary Fibrosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Pulmonary Fibrosis. Report includes an overview of trial numbers and their average enrollment ... Read More
-
Idiopathic Pulmonary Fibrosis Disease Treatment: Global Markets
... forecast trends and sales through 2024. Important manufacturers, technologies and factors influencing demand are discussed. The market has been segregated geographically into the U.S., Japan and five major European markets (Germany, France, Italy, Spain, and ... Read More
-
Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology (Recombinant Vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated and Subunit Vaccines, and Toxoid Vaccines); Disease Indication (DTP (Diphtheria Tetanus t
... Pertussis), Influenza, Hepatitis, Respiratory Syncytial Virus (RSV), Dengue, Cytomegalovirus (CMV), and Other Diseases); Route of Administration (Oral, Injectable, and Other Routes of Administration); Patient Type (Pediatric Patients, and Adult Patients) and Geography The vaccines market ... Read More
-
Pulmonary Arterial Hypertension - Pipeline Review, H2 2020
... Hypertension (Cardiovascular) pipeline landscape. Pulmonary arterial hypertension (PAH) is a type of high blood pressure that occurs in the right side of the heart and in the arteries that supply blood to the lungs. Symptoms ... Read More
-
Pulmonary Arterial Hypertension - Global Drug Forecast and Market Analysis to 2029
... (Group 1) within the World Health Organization’s (WHO’s) classification of the different types of pulmonary hypertension. PAH is characterized by an abnormal rise in the resting mean pulmonary artery pressure (PAP) (>25mmHg compared with normal ... Read More
-
Cystic Fibrosis (CF) – Pipeline Insight, 2020
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Cystic ... Read More
-
Global Tracheostomy Products Market 2020-2024
... period. Our reports on tracheostomy products market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Respiratory Diseases Drugs Investment Global Outlook 2020
... the economic slowdown across countries owing to the pandemic outbreak. The market is then expected to recover and grow at a CAGR of 4.38% from 2020 to reach $73.86 billion in 2023. Respiratory Diseases Drugs ... Read More
-
Anesthesia and Respiratory Devices Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026
... that can shape up the future of the Anesthesia and Respiratory Devices market including the COVID-19 pandemic implications for Anesthesia and Respiratory Devicess industry. The report presents market size forecasts across types, applications, end users ... Read More
-
Global Artificial Heart Lung Machines Market Growth 2020-2025
... market size will reach $ 288.5 million by 2025, from $ 257.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Artificial Heart Lung Machines ... Read More
-
Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2029
... or alveoli, in the lungs. This condition occurs when the lung tissue becomes thick and stiff for unknown reasons. Over time, breathing becomes difficult due to fibrosis caused by permanent scarring in the lungs (NHLBI, ... Read More
-
Pulmonary Arterial Hypertension - Epidemiology Forecast to 2029
... et al., 2010; Simonneau et al., 2004). In PAH, blood vessels in the lungs are narrowed, blocked, or destroyed. The damage slows blood flow through the lungs (Mayo Clinic, 2020). This results in progressively increasing ... Read More
-
Global Respiratory Care Devices Market (by Product, Type, Application, End User, Geography), Recent Developments, Company Profiles - Forecast to 2026
... by 2026. Respiratory care is a healthcare specialty, which is focused on improving cardiopulmonary functions and promoting health & wellness. Respiratory care devices are used for the diagnosis, treatment, and monitoring of patients who are ... Read More
-
Global Human Respiratory Syncytial Virus Drugs Market Research Report 2020-2024
... Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) ... Read More
-
Respiratory Inhalers Market - Global Outlook and Forecast 2020-2025
... expected to grow at a CAGR of over 9% during the period 2019–2025. The global respiratory inhalers market is one of the steadily growing segments in the medical devices market. The steady growth can be ... Read More
-
Global Patient Circuit Market By Type (Open, Closed, Semi-Closed), By Use (Single Use v/s Reusable), By Application (Anesthesia, Respiratory Dysfunction, Others), By End User (Hospitals, Ambulatory Centers, Others), By Region, Competition, Forecast & Oppo
... 2025 A patient circuit or a breathing circuit is a medical device which connects a patient and a ventilator. It brings about an exchange of gases particularly supply of oxygen and removal of carbon dioxide. ... Read More
-
Non-cystic Fibrosis Bronchiectasis (NCFB) – Pipeline Insight, 2020
... clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global ... Read More
-
Respiratory Care Devices
... projected to reach a revised size of US$25.2 Billion by 2027, growing at a CAGR of 6.2% over the analysis period 2020-2027. Therapeutic Devices, one of the segments analyzed in the report, is projected to ... Read More
